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Abstract
Introduction
Mitochondria are known as the powerhouses of the cell. 
They are crucial in producing cellular energy adenosine 
triphosphate (ATP) production, regulating cellular 
activities, such as apoptosis, Calcium (Ca2+) signaling, 
redox homeostasis, etc.(1) Since last decade, cell biology 
researchers found the regulated events of membrane fusion 
and fission of mitochondria, termed as mitochondrial 
dynamics, bring forth this organelle as their main interest, 
together with the mitochondrial network remodeling 
architecture within the cytoplasm.(2-4) Notably, any 
abnormality in mitochondrial dynamics could cause 
bioenergetic defects (5), induce embryonic lethality in 
transgenic animal models (6), also a different group of 
human diseases (7), confirming the crucial role of this event 
in physiopathology (8-10). Many studies demonstrated that 
mitochondria play a role in the essential cellular signaling 
pathways and mitochondrial dynamics are involved in 
regulating cellular activity.(4,11,12) Thus, any perturbation 
in mitochondrial function will affect human pathologies such 
as type-2 diabetes, cardiovascular, and neurodegenerative 
diseases.
 Mitochondria have their own DNA, named mtDNA, 
and maternally inherited, not transmitted through nuclear 
DNA (nDNA). In human, mtDNA is circular, double-stranded 
circular molecule of 16.5 kb, encoding 13 subunits of the RC 
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R E V I E W  A R T I C L E
BACKGROUND: Mitochondrial dysfunction known to be associated with most of human inherited disorders and diseases, including 
neurodegenerative disorders, cardiomyopathies, metabolic 
syndrome, muscle weakness, cancer, also obesity. 
CONteNt: Mitochondria charges for multiple anabolic 
and catabolic circuitries, as the main provider for adenosine 
triphosphate (ATP). Mitochondria also responsible for cell-
wide stress responses and control non-apoptotic cell death 
routines, such as autophagy and regulated necrosis. In other 
words, mitochondria play an extended role in regulating 
cellular functions, both vital and lethal, from physiological 
metabolism to stress responses and death to maintain adult 
tissue homeostasis. Furthermore, mitochondria are crucial 
for both embryonic and postembryonic development. 
Therefore,  any  defect  or  alteration  in  mitochondria 
signaling pathways will lead to a large number of diseases 
in human, including premature aging, neurodegenerative 
disorders, muscle weakness, cardiovascular disorders, and 
cancer.
SUMMARy:  Mitochondria perform a dynamic, integrated 
interconnected network, to maintain tissue homeostasis, 
beyond the cell boundaries and regulating cells and tissues 
communication. Certainly any mitochondrial dysfunction 
could direct to neurodegenerative diseases and metabolic 
disorders.
KeywORDS: mitochondria, UPR, mitochondrial quality 
control, proteostasis, mitohormesis, mitochondrial diseases
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complexes I, III, IV and V, while complex II is composed 
of four nucleus-encoded subunit with no contribution from 
mtDNA. The mtDNA contains 22 tRNAs, and 2 rRNA 
genes, which form the RNA apparatus serving the in situ 
translation of the 13 mtDNA-encoded respiratory chain 
subunits. In normal individuals, mtDNAs are all identical to 
each other (homoplasmy), present in hundreds to thousands 
of copies in different cell types. Heteroplasmy refer to the 
pathogenic mtDNA mutations, which is frequently co-exist 
in variable amount with wild-type mtDNA molecules. The 
remainder proteome in mitochondria is encoded by nuclear 
genes, consist of almost 1500 polypeptides translated in the 
cytosol into proteins, and imported to target the organelles 
by an active process.(13)
 Mitochondrial diseases can present at any age on any 
organs, affect one in 2,000 individuals. Most mitochondrial 
diseases occurred due to the genetic mutations that disrupt 
mitochondrial gene expression (mtDNA replication and 
transcription, and mitochondria mRNA translation) (14-
16), affect to mitochondrial oxidative phosphorylation 
because the assembly of the respiratory chain enzyme 
complexes and ATP synthase in the mitochondrial inner 
membrane folds called cristae was failed. This assembling 
need nutrient-derived reducing equivalents to generate 
an electrochemical potential across the inner membrane 
and is essential for organelle functions.(17) This might be 
explained how a dysfunction in mitochondria could lead to 
many cell-specific stress responses and will induce a range 
of human diseases, but the exact mechanism remains poorly 
understood.(18)
Mitochondrial Biogenesis and Functions
(20) The discovery of peroxisome proliferator-activated 
receptor (PPAR)-γ coactivator (PGC)-1α and family (PGC-
1b and PGC-1-related coactivator (PRC)) as key players in 
the regulation of energy metabolism open a major finding 
of how transcription factors controlling mitochondrial 
biogenesis by regulating overlapping gene expression 
programs.(21,22) 
 Mitochondrial biogenesis is an orchestrated process 
tightly regulated by the activity of both mitochondrial and 
nuclear factors. Ninety percent of mitochondrial proteins are 
nuclear-encoded, except the respiratory chain complexes 
formation which encode by both nucleus and mitochondria. 
The two genes had to be synchronous for transcription and 
translating the protein needed for new organelles generation. 
Any imbalance will lead to proteotoxic stress and subsequent 
activation of mitochondrial turnover mechanisms.(23-25) 
After transcription and translation process, nuclear-encoded 
proteins are folded through some process coupled to the 
translocase of the outer membrane (TOM)-mediated import 
(26), then due to their presequence directed to particular 
mitochondrial subcompartments:  the outer mitochondrial 
membrane (OMM), the intermembrane space (IMS), the gel-
like structure called inner mitochondrial membrane (IMM), 
or the matrix (27). These steps are regulated by the AMP- 
activated protein kinase (AMPK), the mechanistic target 
of rapamycin (mTOR), and insulin-like signaling (ILS) 
pathways, together with the signaling cascades triggered by 
calcium and nitric oxide.(28-32)
 The key components for mitochondrial biogenesis are 
nuclear respiratory factors (NRF)1 and NRF2.(25) NRF1 
transcriptional activity is methylation-dependent.(33) 
NRF2, or also known as GA-binding protein transcription 
factor (GABP), controls the expression of mitochondrial 
transcription factors (TFAM, TFB1M, TFB2M) and 
components of the respiratory chain (COXIV sub- units).(34) 
In mice, sirtuin (SIRT)7 deacetylases GABP-b1 and trigger 
its binding to GABP-α thus increasing its transcriptional 
activity.(35) AMPK as an additional regulator of 
mitochondrial homeostasis, in response to nutrient depletion, 
inhibit mTOR to promote mitophagy and activate Unc-51 
like autophagy activating kinase 1 (ULK1). Otherwise, 
in rat hepatocytes, AMPK-mediated phosphorylation of 
SIRT1 results in the PGC1-α deacetylation and subsequent 
activation, apparently as adaptive compensation response 
for enhanced mitochondrial turnover.(36) Aside from energy 
production as their main role, mitochondria also involved in 
major cellular processes, including ion homeostasis, lipid 
metabolism, and initiation of apoptotic cell death.
Mitochondria employ a series of biochemical activities for 
providing oxidative ATP production in eukaryotic cells.
(19) Mitochondria has an inner impermeable membrane, 
and an outer permeable membrane up to approximately 
5 kd molecular mass, to separate it from the cytoplasm. 
Acetyl-CoA oxidation will derive nicotinamide adenine 
dinucleotide (NADH) and flavin adenine dinucleotide 
(FADH) as the electron donors. This electron was needed 
for electron transport chain of the mitochondrial inner 
membrane, in order to establish an electrochemical proton 
gradient across the membrane. When the proton transferred 
a voltage potential and a pH gradient is produced, and 
used by the membrane bound ATP synthase to drive the 
synthesis of ATP or by uncoupling proteins to generate heat.
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Figure 1. endogenous sources of ROS signal.(38) (Adapted with 
permission from Lippincott Williams and Wilkins).
Mitochondria as Regulators of Reactive oxygen species (ROS) and Calcium Signaling
Previously, ROS viewed as a toxic by-product of 
mitochondrial respiration, and by its name we can advise that 
it is more chemically reactive than O2, then ROS accused of 
being cellular damaging agents towards lipids, proteins and 
DNA. Recent studies suggested its appreciation as a mediator 
in numbers of cellular signaling pathways (37-40), including 
growth factor signaling, hypoxic signal transduction, 
autophagy, immune responses, and stem cell proliferation 
and differentiation.(41) These propose the perspective of 
ROS from unwanted product of an imperfect system into 
a nature specific selection for their signaling, evolving our 
knowledge about the cellular antioxidant defense system. 
Many oxidant species gain advantages from ROS specificity 
of signaling, either in chemical reactivity, stability, and lipid 
diffusion capabilities. O2−, one of ROS species, is generated 
when O2 go through one electron reduction by cytosolic 
nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidases (NOXs) or n mitochondrial electron transport 
chain (ETC) complexes I, II, and III  (Figure 1).(42,43) 
O2− generated by the mitochondrial ETC is released into the 
matrix and with help of superoxide dismutase 1 (SOD1), 
cytosolic O2− is rapidly converted to H2O2.(44) O2− also 
release complex III into the intermembrane space which 
can cross over through voltage-dependent anion channels 
into the cytosol and be converted into H2O2 by SOD1.(45) 
Moreover, H2O2 also produced as a by-product of protein 
oxidation in the endoplasmic reticulum (ER), as the end 
product in many peroxisomal oxidation pathways such 
as in the β-oxidation of very long-chain fatty acids, and 
by a wide range of enzymes including cytochrome P450.
(46) Important thing to note is that ROS specific target at 
proximal location to these oxidant-generating systems. By 
this paradigm shifting towards ROS, we need to elucidate 
the molecular mechanism of ROS signaling in facilitating 
oxidation, and the possibilities of its potential for providing 
new therapeutic avenues for a myriad of diseases linked 
with excessive ROS.(37)
 Ca2+ signaling has become the star for coordinating 
various extracellular stimuli and triggers the cellular 
function during the past century.(47,48) Recently 
mitochondrial Ca2+ uptake take over the stage as the 
controller for intracellular Ca2+ signaling, cell metabolism, 
cell survival and other cell-type specific functions as it 
effectively buffering cytosolic Ca2+ levels and regulating 
the effectors. Mitochondrial Ca2+ transporters reveals 
recently, draw the attention for investigation and molecular 
intervention.(49) Accumulation of Ca2+ in mitochondria 
regulates the organelle metabolism, including its main task 
to produce ATP by oxidative phosphorylation. Three matrix 
dehydrogenases of mitochondria were activated by low 
concentration of Ca2+: pyruvate dehydrogenase is regulated 
by a Ca2+-dependent phosphatase, and α-ketoglutarate- and 
isocitrate-dehydrogenases are regulated by direct binding 
of Ca2+ to these enzymes.(50-52) When Ca2+-sensitive 
dehydrogenases stimulated, NADH availability increased 
and the electrons flow down the respiratory chain, proposed 
increased ATP synthesis adjust to the cells need.(53) Some 
genetic disorders affect mitochondrial function due to the 
defect in respiratory chain thus reduce the driving force for 
Ca2+ transfer, therefore the ATP production also reduced.
(54,55)
 Ca2+ accumulated in mitochondrial matrix through 
IMM across the steep electrochemical gradient via an 
electrogenic pathway with help of Ca2+ uniporter (MCU). 
MCU has a Vmax of >1400 nmol Ca2+ per mg of protein 
per min and can be inhibited by Ruthenium red1 and 
lanthanides.(56-58) Na+/Ca2+ exchangers (mNCX) and 
mitochondrial H+/Ca2+ exchangers (mHCX) counteract the 
MCU-Ca2+ accumulation, and insensitive to ruthenium red 
but can be inhibited by benzothiazepine analogues, such as 
diltiazem, clonazepam and CGP-37157.(59-61) 
 Besides its property as Ca2+-binding proteins, 
mitochondria in other side may act as fixed buffer of 
Ca2+ large elevation from a subcellular domain. This will 
influence cellular Ca2+ signals, and hence cell function.
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Figure 2. Role of mitochondrial 
Ca2+ uptake for AtP production 
and ROS elimination.(62) (Adapted 
with permission from American Heart 
Association).
Quality Control of Mitochondrial Proteostasis
(49) Mitochondrial Ca2+ performs two manner during 
physiological variations of workload (Figure 2). Uptake 
via the mitochondrial Ca2+ uniporter is required to meet 
the energy supply demand, while keeping the antioxidative 
capacity in a reduces state so ROS emission won’t be 
disproportionate.(62) The architecture of mitochondrial 
calcium uniporter is shown in Figure 3. 
In a cell, mitochondria best known as essential organelles, 
and the powerhouse in generating large amount of energy 
from food into ATP by an electrochemical proton gradient 
across the inner membrane activate the ATP synthases. 
Mitochondria manage the central functions for amino 
acids and lipids metabolism, as well as iron-sulfur clusters 
and heme biosynthesis.(66-69) Mitoproteases is a highly 
regulated proteolytic reactions performed in mitochondria, 
including protein synthesis, quality control, mitochondrial 
biogenesis and dynamics, mitophagy and apoptosis. Any 
impaired or dysregulation function of this degradative 
function of mitochondria is associated with aging-related 
diseases such as neurodegenerative disorders, metabolic 
syndromes and cancer.(70)
 Current proteomics and bioinformatics approaches 
make it possible to define a comprehensive inventory 
of mitochondrial proteins that role in maintaining 
mitochondrial healthy function.(71,72) Encoding by two 
different genomes, mammalian mitochondria harbor their 
own genome, encoding for 13 polypeptides aside from those 
synthesized by nuclear genes. The mitochondrial-encoded 
proteins compose the core components of the respiratory 
chain complexes, assemble with imported of nuclear-
encoded proteins to achieve efficient respiratory chain 
complex of mitochondria. Discoordination of this process 
may result in unpartnered proteins, which are prone to 
misfolding or aggregation. ROS, as an inevitable byproduct 
of the generation of ATP through oxidative phosphorylation, 
also become another challenge imposed upon mitochondria. 
When reacting with proteins, DNA or lipids, ROS could 
result in accumulation of oxidatively damaged products, 
making them more prone to oxidative damage, and lead 
to depolarization of the mitochondrial inner membrane. 
This could propose the outer membrane permeabilization, 
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Figure 3. Mitochondrial calcium uniporter architecture and 
regulation.(62) (Adapted with permission from American Heart 
Association).
make it possible for pro-apoptotic proteins to release from 
intermembrane space into the cytosol, and initiating the 
apoptotic cascade.(73,74) Mitochondria has developed its 
own mechanism for quality control involving damaged 
protein or organelles removal to keep the homeostasis of 
its functional network.(75-79)  Blunted quality control will 
affect in defense pathways for cellular homeostasis and 
survival and of course the overall cell health, correlated 
to aging, prevalent neurological disorders like Parkinson's 
disease and spinocerebellar ataxia.(80) Mitoproteases 
together with the cytosolic ubiquitin-proteasome system 
(UPS) form the first line of cellular defense by facilitating the 
removal of damaged, oxidized or misfolded mitochondrial 
proteins.(81) Figure 4 explain the mechanisms of 
mitochondrial quality control briefly.
Figure 4. Mechanisms of mitochondrial quality control.(81) (Adapted with permission from Elsevier).
 The first line of mitochondria, from bacteria to higher 
eukaryotes defense mechanism action in the molecular 
level, involves the conservation of intraorganellar protein 
quality control machinery, including chaperon and 
various proteolytic enzymes. UPS and a mitochondria-
specific unfolded protein response (UPR) also influence 
mitochondrial protein quality control, by constricting the 
increasing of misfolded proteins in the organelle.(82,83) The 
second line for quality control emerge due to the dynamic 
nature of mitochondria itself. The organelles naturally tend 
to constantly fusing and dividing mediated by dynamin-
like GTPases in the OMM and IMS.(84,85) By fusion, 
a damaged mitochondrion, means it’s defect in certain 
components, will fuse with a healthy neighbor and replenish 
its stores.(75) The third stage of these quality controls gate 
occurs on a cellular level, where the mitochondrial damage 
were more extensive that the entire cell need to be totally 
turnover through apoptosis.(86,87)
 On contrary, mitochondria fissions aim to increase the 
organelles numbers within the cells prior biogenesis, and 
separate the defect organelles for autophagic degradation 
(88,89), and then by fusion these components will be 
mix and distribute evenly. Thus, by fusion and fission 
mitochondrial biogenesis, distribution of mtDNA, and 
proteome could be facilitated. Practically, chaperones and 
proteases protect mitochondria protein-folding environment 
from inevitable errors in expression and assembly as well 
as prevent the prevent accumulation of unfolded and 
orphaned subunits.(76) Recent comprehensive knowledge 
in mitochondrial genetics improve the diagnosis to prevent 
severe mitochondrial disease, and had a major impact on 
patient care as well as rise new challenges for therapies in 
mitochondrial disorders.
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Figure 5. Biogenesis pathways of mitochondrial proteins.(67) (Adapted with permission from Springer Nature).
Mitochondrial and Nucleus Communication
Mitochondria import more than 1,000 different proteins 
from the cytosol to perform the bioenergetics, metabolism, 
and apoptosis function. The protein import machinery 
was assumed to be constitutively active and not depend 
on any exact regulation. After all, recent studies found a 
multiple levels of mitochondrial protein import regulation 
which were connected to cellular metabolism, signaling, 
stress, and pathogenesis of diseases. Mitochondrial fitness 
can be monitored by this activity and also represent the 
biogenesis regulation, composition, and turnover of the 
organelle.(69) Nucleus-encoded mitochondrial precursor 
proteins possess targeting signals which are recognized 
by receptors on the mitochondrial surface, and direct 
the precursors to their functional destination in the 
mitochondrial sub-compartments. These targeting signals 
can be distinguished into two main groups.(63,64) The 
first group is the amino-terminal extensions of precursors. 
This is the classical mitochondrion-targeting signals. Their 
presequences removed  after  import  into  mitochondria  by 
a  proteolysis. The second one are some precursor proteins 
with no particularly cleavable extensions but contain 
internal targeting signals that remain part of the mature 
protein including  different  types  of  precursor  proteins 
and targeting signals (Figure 5).(67)
 Many researches focus on excavating these 
structural analyses of mitochondrial import components, 
besides of single-particle electron microscopic analysis 
of purified translocase complexes (90-93), receptor 
domains, mitochondrial chaperones and the processing 
peptidase MPP (94-100). High resolution structures of 
the membraneintegrated translocation channels, were also 
important to dig the molecular mechanisms of membrane 
translocation including that of preproteins in transit.
 Mitochondrial function was controlled by nuclear 
transcription, including the organelle function and capacity 
coordination, in response to intrinsic and extrinsic signals 
either  alterations  to  the  cell's  redox  state,  nutrient 
deprivation, and (in muscle) exercise.(101-103) These 
will increase in mitochondria biogenesis, boost the 
mitochondrial mass and bioenergetic capacity. An array 
of transcription factors (TFs) together with co-activators 
activate and coordinate nuclear and mitochondrial genes 
expression.(104,105) NRF-1 and NRF-2 are the principal 
TFs for biogenesis, by controlling the expression of 
key mitochondrial components involved in oxidative 
phosphorylation (OXPHOS), haem biosynthesis, the 
function and regulation of mtDNA, and antioxidant 
defences.(106) The oestrogen related receptor (ERR)-α, the 
cAMP response element (CREB), and the Ying Yang 1 (YY-
1) transcription factor also role as TF in the regulation of 
mitochondrial genes. Other TFs such as ERR-α regulates 
oxidative metabolism through its control of β-oxidation 
related genes (106), and CREB and YY-1 are involved in 
the expression of ETC. protein components.(107,108) All 
of them with transcriptional co-activators in the nucleus 
integrates into the program of biogenesis.(109)
 Retrograde (RTG) signaling occurred as a respond to 
altered mitochondrial bioenergetic state, the expression of 
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nuclear encoded genes will be increased, and compensating 
the effects of mitochondrial dysfunction or stress. Rather 
than being a part of mitochondrial quality control systems, 
RTG system are the stress response pathways complementary 
to mitochondrial quality control, which activate counter 
mechanisms to bioenergetic deficiencies caused by 
mitochondrial dysfunction. There were not enough studies 
in mammalian cells about this, but some researches in yeast 
have provided interesting observations that perturbations 
to mitochondria such as the loss of mtDNA (i.e., petite or 
rho0 cells) lead to the activation of TF by RTG1, RTG2, and 
RTG3 (RTG1-3) proteins. RTG signaling in yeast induce 
the activation of the glyoxylate cycle and the upregulation 
of fatty acid β-oxidation thus proposed the alter in the 
metabolic function, involving abundant variety of carbon 
sources, such as acetate, and compensating for a reduction 
in capacity or lack of OXPHOS.(110) Involvement of TOR 
signaling in the RTG signaling pathway open a possibility 
of such system in higher eukaryotes, since TOR signaling 
also found from yeast to humans although its sphere of 
activity may be slightly changed between species.(111)
 Mitochondrial genome can communicate and function 
synergistically with nuclear expression regulate by specific 
sequence alterations that categorize mtDNA in haplogroups 
as mtDNA haplotypes, besides being useful to trace 
maternal phylogenetic lineages.(112) mtDNA variations are 
specifically associated with disease phenotypes related to 
specific sequence alterations in mitochondrial components, 
and can be measured through the bioenergetic and other 
mitochondria functional aspects, such as a decrease in 
respiratory function.(113) There are large groups of human 
mtDNA pathogenic mutations known to be correlated with 
clinical phenotypes (114), such as the A3243G mutation in 
the gene encoding mitochondrial tRNALeu (115), is known 
to be associated with mitochondrial encephalomyopathy, 
lactic acidosis, and stroke-like episodes (MELAS), and also 
promote the development of some other clinical phenotypes.
(109) We could conclude that mismatch between the 
two genomes, the nuclear and mitochondrial affect in 
mitochondria quality and cellular health.(109,116)
deprivation and also selectively eliminates organelles in 
order to maintain their number and quality control.(89)
 Autophagy selectively eliminate mitochondria, in 
conjunction with mitochondrial biogenesis, to maintain 
the steady-state mitochondrial number that are needed to 
meet metabolic demand. Mitophagy through some distinct 
steps selectively removed any defective or superfluous 
mitochondria and target them to autophagosomes to 
maintain quality control (Figure 6).(89) ‘Mitochondrial 
quality control’ involving the coordination of mitochondrial 
dynamics, mitophagy, and biogenesis to keep up a healthy 
pool of mitochondria. Mitochondrial dynamics refer to 
its constantly modified morphology by fission and fusion 
events, all while they are being shuttled throughout the cell. 
This way, fission and fusion allow damaged mitochondria to 
complement each other. PTEN-induced kinase 1 (PINK1)/
parkin pathway affecting fission and fusion, but it is not 
known how this could cause dopamine neuron degeneration. 
Under stressful conditions, such as nutritional deprivation, 
two damaged mitochondria with mutations in different 
genes can fusion and allow functional complementation by 
RNA and protein components diffusion result in a newly-
formed mitochondria and rescuing its function.(119) The 
lack of mitochondrial function rescuing ability will render 
cells to become more vulnerable to mitochondrial deficits. In 
reverse, by fission mitochondria break into smaller pieces to 
facilitate transport and autophagic degradation of damaged 
mitochondria. Surprisingly, fission often leads to dissociation 
the damaged components from resulting mitochondria, 
resulting in one highly functional mitochondrion and 
another damaged mitochondrion with reduced membrane 
potential.(120) So, impaired fission could risk to the ability 
of mitophagy in recognizing the dysfunctional mitochondria 
and even to transport them to and from neurites, which is 
essential in long and energetically demanding cells, such as 
neurons.(121)
 Therefore, mitochondria quality controls include 
fission and fusion, mitophagy, transport, and biogenesis. 
Recent studies on Parkinson’s disease (PD), a progressive 
neurodegenerative disease that causes a debilitating 
movement disorder, implicated s defect in parkin and 
PINK1 related to each axis of mitochondrial quality control. 
Mutation in autosomal recessive PD at two genes encode 
OMM kinase PINK1 (122) and the cytosolic E3 ubiquitin 
ligase parkin (123), two proteins involved in suppressing 
mitochondrial damage in flies (124-126). Impaired in 
these will lead to loss of flight muscle and dopaminergic 
neurons, also affecting to male sterility that is ameliorated 
by promotion of mitochondrial fission.(127-129)
Mitophagy
One of the cellular components catabolism process including 
cytosol, organelles and protein aggregates, is autophagy, 
over their encapsulation by a double-membrane structure 
known as the autophagosome.(117,118) Autophagy will 
recycles intracellular components to compensate for nutrient 
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Figure 6. Non-selective autophagy and mitophagy have different roles.(89) (Adapted with permission from Springer Nature).
 In autosomal recessive PD, parkin gene mutation is the 
most common cause. The gene encodes a 465-amino acid 
E3 ubiquitin ligase capable of mediating mono- or poly-
ubiquitination using different ubiquitin linkages via lysine 
27, 29, 48, and 63 of ubiquitin. Investigation from mouse 
model and postmortem PD brain samples showed that 
parkin is inactivated by post-translational modifications, 
including oxidation, nitrosylation, addition of dopamine, 
and phosphorylation by c-Abl, which is important for stress-
activated nonreceptor tyrosine kinase and is activated in 
sporadic PD brains and in animal models of PD.(121)
 Autophagy and apoptosis manage the turnover 
of organelles and proteins within cells, and of cells 
within organisms, respectively. Many stress pathways 
sequentially bring up autophagy and apoptosis within the 
same cell. Commonly, autophagy and apoptosis blocking 
and shuts off each other, for exceptional in some special 
cases autophagy or autophagy-relevant proteins will 
induce apoptosis or necrosis, where autophagy degrade 
the cytoplasm excessively, leading to ‘autophagic cell 
death’. Communication between autophagy and cell death 
pathways influences the normal clearance of dying cells, 
as well as immune recognition of dead cell antigens. Thus, 
the relationship between autophagy and apoptosis has 
an essential affect in pathophysiological consequences.
(130,131)
Mitochondrial UPR and Mitohormesis
Mitochondrial function affects a lot of essential cellular 
and organismal function, therefore many cell’s mechanisms 
or pathways have evolved to monitor mitochondrial 
function and provide a fast respond against mitochondrial 
stress to recover organelle activity, referred as the RTG 
responses. This pathways upstreaming the initial signals 
of mitochondria to communicate with cytosol and nucleus 
and impact gene transcription and protein synthesis in a 
protective manner.(132) One potential mechanism to asses 
mitochondrial quality involving the organelle metabolites 
such as ATP or iron-sulfur clusters (133) and monitoring 
mitochondrial protein import efficiency (134). In order 
to function properly, over than 1,000 proteins composing 
mitochondria, of which ~99% are encoded by nuclear genes 
and translated on cytosolic ribosomes, then later imported 
into mitochondria, where they are appropriately folded and 
assembled. Transit across the mitochondrial inner membrane 
requires the Tim23 complex and a completed tricarboxylic 
acid cycle (TCA) cycle and OXPHOS system to keep the 
membrane potential and the mitochondrial chaperones 
located within the matrix.(65,135,136) Therefore, the 
mitochondrial function could be described by the protein 
import efficiency.
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 Proteostasis can be briefly determined as protein 
homeostasis, means all the cellular pathways that govern 
the production, folding and degradation of proteins, 
necessary for cellular and organismal functionality and 
survival. The UPR is a complex pathways of cellular stress 
response to ensure proteostasis in different subcellular 
compartments, with finely communicated with the nucleus, 
have evolved in the cytosol, endoplasmic reticulum and 
mitochondria. Proteostasis dysfunction was correlated to 
several age-related diseases due to protein aggregation.
(137) Mitochondrial unfolded protein response (UPRmt), 
just recently discovered, not like endoplasmic reticulum 
(UPRER) and the cytosolic heat shock response (HSR) that 
have been first extensively studied (138,139), also role in 
on the complex relationships between mitochondria and the 
nucleus (82,140).
 Proteostasis in the mitochondria is provided by an 
elaborate PQC network, composed of two main functional 
groups of proteins, chaperones and proteases (76,79). 
Chaperones mtHsp70, Hsp60 and Hsp10 fold and assemble 
proteins that are imported into the mitochondria and refold 
damaged mitochondrial proteins. Each mitochondrial 
compartment has specific ATP-dependent protein quality 
control (PQC) proteases to digest any excess proteins 
that are unassisted by chaperones: the ClpXP and Lon 
proteases in the matrix, the i-AAA (Yme1L1) and m-AAA 
proteases (Afg3l2 and Spg7), acting in the IMS and matrix, 
respectively. These PQC chaperones and proteases are 
induced upon mitochondrial proteotoxic stress as a result of 
a RTG mitochondria-to-nucleus signaling termed UPRmt, 
or can be described as a transcriptional response due to 
mitochondrial dysfunction or the accumulation of unfolded 
proteins within mitochondria in the cell. 
 Studies performed to revealed the pathways using 
mitochondrial chaperones and proteases as UPRmt 
biomarkers, found many conditions to trigger UPRmt, most 
of which interfere with the mitochondrial proteostasis, 
including  disturbing  the  PQC  system  or  by  increasing 
the  load  of  damaged,  unfolded  or  unassembled  proteins, 
with  the intention to alleviate proteostatic stress in 
mitochondria and promote cell survival along with the repair 
and recovery of defective mitochondria.(141,142) Thus 
UPRmt maintain the stability of mitochondrial function, 
metabolic adaptations, as well as an innate immunity.(143) 
While impaired protein quality control and accumulation 
of misfolded and unfolded proteins direct to proteostasis 
impairment role in age-related decline, increasing the 
expression of chaperone, limiting translation, or increasing 
protein turnover otherwise has been implicated in shifting 
mitochondrial dysfunction into lifespan extension by 
hermetic mechanism.(142)
 UPRmt is induced by manipulating ETC via 
downregulation or inhibition of single (or groups of) ETC 
components, either by encoded mtDNA or nDNA (144), 
resulting a mismatch between mtDNA and nDNA encoded 
ETC subunits and an orphaned unassembled subunits 
conceived. This subunit need to stay associated with 
chaperones, termed as mitonuclear protein imbalance.(144) 
ETC subunits also downregulated by cco-1 (complex IV) 
RNA interference (145,146), in isp-1 (complex III) or clk-
1 (ubiquinone synthesis) mutant strains (146,147), or by 
using pharmacological ETC inhibitors, such as antimycin 
(148,149) and rotenone (148). Therefore, mitochondrial 
biogenesis activation by resveratrol or rapamycin (144), or 
NAD+ levels boosting by the NAD+ precursor, nicotinamide 
riboside (NR), or by inhibiting NAD+ consumption, as seen 
after treatment with PARP inhibitors (150), trigger UPRmt 
by similar mechanisms. However, in NAD+ level raising, 
mitonuclear imbalance created due to specifically increasing 
of transcription and translation of mtDNA-encoded ETC 
subunits, thus triggers the UPRmt.(151)
 Under stress, mitochondria will activate several 
lines of defense. Started with temporarily blocking the 
production and import of new mitochondrial proteins. 
General control nonderepressible (GCN)-2, a specific 
kinase in worm (152), and protein kinase R (PKR) in 
mammals (147), phosphorylate eIF2a and leads to global 
translation attenuation. Yme1l1 protease in mammals, 
selectively degrades the translocation pore component 
Tim17A and specifically  reduce  the  mitochondrial 
import and functions, consistent  with  the reallocation of 
ATP production to glycolysis in the cytoplasm.(153,154) 
In  stress  condition,  both  mitochondrial  dynamics 
and mitophagy pathways contribute to reconstitution of 
cellular homeostasis, by redistribution and eliminate of the 
irreversibly damaged elements of mitochondrial network. 
Under strong mitochondrial stress, insufficient levels of 
mitophagy and UPRmt activation will induce apoptosis 
and has  negative  systemic  effects  on  whole  organism 
physiology.(76,79)
 Many publications so far have provided useful 
information   about   the  communication  between 
mitochondria and nucleus, also how its roles including 
UPRmt pathways in lifespan regulation from simple 
model organisms  tomammals.  However, UPRmt is 
a transcriptional response that affects over 400 genes 
controlling different aspects of cell physiology, so we 
are facing a scientific challenge for years to come to find 
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which one is the most important and the most available to 
be manipulated in ameliorating the defects associated with 
mitochondrial dysfunction.(140,143)
 In mild stress, mitochondrial rapidly activate a 
coordinated response in cytosolic signaling pathways 
that ultimately alter nuclear gene expression, named 
mitohormesis, and leave the cell less susceptible to 
subsequent perturbations. A comprehensive understanding 
of mitohormesis will provide a better insight into our 
susceptibility for disease and potentially provide a unifying 
hypothesis for why we age.(155) Hormesis in general can 
be defined as any cell response that exhibits a biphasic 
response to exposure to increasing amounts of a substance 
or condition.(156) Here, we focus on one form of hormesis, 
termed mitohormesis, briefly defined as a respond to mild 
mitochondrial stress due to any insults, exhibit a broad and 
diverse cytosolic and nuclear response. This response could 
be varied but appears to induce a wide-ranging cytoprotective 
state generating in long-lasting metabolic and biochemical 
changes and finally may reduce our susceptibility for disease 
and expand out lifespan.(155,156) Then we may warp up 
that mitochondrial stress induce mitohormetic response 
which provided both short term metabolic benefits and the 
potential for long term benefits in increased stress resistance 
and longevity.
Mitochondrial Diseases
Human mitochondrial disorders are long-term, genetic, 
often inherited disorders, in consequence of mutations in 
mitochondrial and/or nuclear DNA that lead to mitochondria 
fail to produce enough energy for the body to function 
properly.(15) Currently, mitochondrial diseases are still 
incurable, so available treatments only help to relieve the 
symptoms. The diseases can manifest at any age, at any 
organ or organ system, including in multiple organs that 
may have no apparent functional links to each other, such 
as the brain and liver, or pancreatic β-cells and the auditory 
system, and can be inherited, either from an autosome, the 
X chromosome, or maternally depending on where the gene 
defect lies. Children may recover from one phenotype and 
later develop another ones.(17,18,157) We don’t have a 
comprehensive understanding about the natural history of 
mitochondrial disease until recently, but longitudinal cohort 
studies involving a large population indicating clinical 
progression in mitochondrial disorders caused by both 
mtDNA and nuclear gene mutations.(158)
Genes identification for mitochondrial disorders lead to better 
mechanisms understanding, such as mutations affecting the 
structural subunits of the mitochondrial respiratory chain 
(159) was accompanied by the molecular dissection of the 
assembly apparatus for complexes IV (160), then I, III (161) 
and finally V (162). Further observation also showed dual 
functions and multiple functions in several assembly protein 
or the structural peptide components of complex I.(163) The 
most interesting finding is that most sophisticated disease 
mechanisms turn out not to connected directly to oxidative 
phosphorylation and ATP synthesis, and in adult, the single 
most important group heading to disorders affecting the 
maintenance of mtDNA.(164)
 Majority abnormalities in mtDNA expression 
associated with mtDNA depletion due to insufficient and/
or unbalanced deoxyribonucleoside triphosphate (dNTP) 
pools, impact in aberrant mtDNA maintenance and 
translation then lead to protein stress (resulting from defects 
in translation or unbalanced translation of respiratory chain 
components that are encoded by mitochondrial and nuclear 
genomes), replication and transcription stress as well as 
stress.(165) A number of credible evidence pointed that 
mitochondrial disorders mainly triggered by mitochondrial 
stress responses because of a primary molecular defect in the 
organelle, and not the defects in oxidative phosphorylation 
per se.(18)
 Mitochondrial stress responses activate the quality 
control pathways then initiate reverting signals in 
mitochondria to activate the nuclear genetic programs for 
organelle maintenance and heighten the quality control. 
Studies in human, mice and cell lines showed a robust 
nuclear transcriptional stress response has also ben induced 
in coping with the defect on mtDNA maintenance and 
translation (165-169), upregulating the genes that carry a 
conserved amino acid response element (AARE) in their 
upstream regulatory region (170). The amino acid response 
element (AARE) functions as the binding site of activating 
transcription factors (ATFs), and was found in different 
isoforms for ER UPR and mtUPR.(171) These, explained 
the complex molecular mechanisms responsible for defects 
of oxidative phosphorylation. A large cohort study recently, 
after last 25 years of intensive studies aimed to explore 
the genetic causes and the pathogenic mechanisms of 
mitochondrial diseases, involving more than 3,000 subjects, 
phenotypic subgroups and the relationship to genotype, 
driven the “proof of concept” successes and providing 
rich natural history data sets to be translated and tested on 
patients. A proof of maturity in mitochondrial medicine, and 
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Conclusion
Mitochondrial function and behavior become central 
for human physiology, and therefore “mitochondrial 
dysfunction” take charge to a wide range of diseases. 
Fortunately, our body has own system for mitochondrial 
“quality control”, monitoring the function of mitochondria in 
various level, and release mitochondrial signals in particular 
stress condition, thus lead to a dramatic effect on oxidative 
and biosynthetic pathways in the cell, affect whole-body 
metabolism. Mitochondrial dysfunction appears to work 
on a close link with nutrient-sensing pathways and the one-
carbon cycle although still poorly understood. Many efforts 
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